# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
TEL AVIV, Israel, Dec. 10, 2020 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. (the "Company") (NASDAQ/TASE: KTOV), a clinical...
Patent covers NT219’s combinations with multiple 2nd and 3rd generation EGFR inhibitors, including osimertinib (TAGRISSO®) TEL...
Gainers Socket Mobile, Inc. (NASDAQ: SCKT) rose 65.8% to $2.42 in pre-market trading after the company reported a rise in e...
https://www.sec.gov/Archives/edgar/data/1614744/000121390020032810/ea128688-6k_kitovpharma.htm
Data Further Support Potential of NT219 to Overcome Cancer Drug Resistance TEL AVIV, Israel, Oct. 16, 2020 (GLOBE NEWSWIRE) --...
Gainers
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Kitov Pharma (NASDAQ:KTOV) with a Buy and adjusts the price target...
TEL AVIV, Israel, Sept. 08, 2020 (GLOBE NEWSWIRE) -- Kitov Pharma Ltd. ("Kitov") (NASDAQ/TASE: KTOV), a clinical-stage ...